Journal
HUMAN CELL
Volume 35, Issue 4, Pages 972-994Publisher
SPRINGER JAPAN KK
DOI: 10.1007/s13577-022-00699-0
Keywords
Ferroptosis; Non-coding RNA; Cancer therapy; Cell death; Oxidative stress
Categories
Funding
- Iran National Science Foundation (INSF) [99019174]
Ask authors/readers for more resources
Cancer cells' resistance to ferroptosis, a new form of regulated cell death, is a major challenge in cancer therapy. Non-coding RNAs have been found to play a role in regulating ferroptosis, and targeting these RNAs could potentially overcome cancer drug resistance. Gene therapy, including gene-editing technology, may aid in developing ncRNA-based ferroptosis targeting as a novel therapeutic strategy for cancer treatment.
Despite the recent advances in cancer therapy, cancer chemoresistance looms large along with radioresistance, a major challenge in dire need of thorough and minute investigation. Not long ago, cancer cells were reported to have proven refractory to the ferroptotic cell death, a newly discovered form of regulated cell death (RCD), conspicuous enough to draw attention from scholars in terms of targeting ferroptosis as a prospective therapeutic strategy. However, our knowledge concerning the underlying molecular mechanisms through which cancer cells gain immunity against ferroptosis is still in its infancy. Of late, the implication of non-coding RNAs (ncRNAs), including circular RNAs (circRNAs), microRNAs (miRNAs), and long non-coding RNAs (lncRNAs) in ferroptosis has been disclosed. Nevertheless, precisely explaining the molecular mechanisms behind the contribution of ncRNAs to cancer radio/chemotherapy resistance remains a challenge, requiring further clarification. In this review, we have presented the latest available information on the ways and means of regulating ferroptosis by ncRNAs. Moreover, we have provided important insights about targeting ncRNAs implicated in ferroptosis with the hope of opening up new horizons for overcoming cancer treatment modalities. Though a long path awaits until we make this ambitious dream come true, recent progress in gene therapy, including gene-editing technology will aid us to be optimistic that ncRNAs-based ferroptosis targeting would soon be on stream as a novel therapeutic strategy for treating cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available